Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Virtual Lung Models Could Shape Respiratory Treatment

By HospiMedica International staff writers
Posted on 19 Sep 2011
A team of international experts is developing a pioneering tool to help tailor the treatment of asthma and chronic obstructive pulmonary disease (COPD) as part of a new European Union (EU) project. More...


The Airway Disease PRedicting Outcomes through Patient Specific Computational Modelling (AirPROM) research team, based at the University of Oxford (United Kingdom), involves scientists from over 10 European countries, who intend to design a computed model of the cells in an airway and a physical model of the airways to assess how air flows through the lungs, and why it becomes obstructed in people with asthma and COPD. By using these unique models, along with existing data from tests which measure lung capacity and highly detailed computerized tomography (CT) scans, the scientists will be able test new therapies, which will enable them to tailor treatments towards the individual.

The aim is to use this information to generate an extensive database of computed and physical models of the whole airways system that will be able to link the characteristics of different airways to a particular treatment in the future, helping health professionals provide personalized treatment for people with COPD and asthma. Another benefit could be to predict how patients might react to different treatments, how the diseases will progress, and the effect on the airways, and to help monitor the future risk to patients.

“Current treatments for COPD and asthma adopt a 'one size fits all' approach,” said project leader Prof. Chris Brightling, MD, MBBS, of the University of Leicester (United Kingdom). “People with these respiratory diseases are therefore missing out on the right treatment to help them manage their condition. These patient-specific models will help us monitor the diseases and how they progress, to make current treatments much more specific and targeted to benefit COPD and asthma patients.”

“Our ability to create a model of the lung using CT scans and other data has advanced greatly along with our ability to measure genes and their activity,” added professor Brightling. “We are also at a point in time where computational models have advanced to the point where they can be used to make sense of thousands of measurements. Now is the time to bring all these elements together to change the way we diagnose patients.”

Related Links:

Airway Disease PRedicting Outcomes through Patient Specific Computational Modelling

University of Oxford
University of Leicester




Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Ultrasound System
FUTUS LE
Gynecological Examination Chair
arco-matic
X-Ray Meter
Cobia SENSE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.